• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Control Hosp Epidemiol . Evaluation of an antigen-test-based strategy to reduce duration of transmission-based precautions for severe acute r

tetano

Editor, Senior Moderator
Infect Control Hosp Epidemiol


. 2023 Aug 4;1-3.
doi: 10.1017/ice.2023.164. Online ahead of print. Evaluation of an antigen-test-based strategy to reduce duration of transmission-based precautions for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in hospitalized patients

Gregory M Schrank[SUP] 1 [/SUP], Michelle Harris-Williams[SUP] 2 [/SUP], Kelly Schiavone[SUP] 2 [/SUP], Martha C Lusby[SUP] 2 [/SUP], Cindy Dove[SUP] 2 [/SUP], Surbhi Leekha[SUP] 3 [/SUP]



Affiliations
Abstract

An academic hospital implemented a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antigen-test-based strategy to facilitate discontinuation of precautions for patients admitted with a positive SARS-CoV-2 test. Of 171 patients that underwent antigen testing, 68% had an initial negative test performed a median of 5 days after admission. Antigen testing reduced isolation time by 144 hours.


 
Back
Top Bottom